Cargando…
HIV-1 gp120 and tobacco smoke synergistically disrupt the integrity of the blood-brain barrier
In the United States, the Centers for Disease Control and Prevention (CDC) terms HIV and tobacco use among the ten most important public health challenges we face today. In the last decade, there has been a remarkable decrease in the number of deaths due to HIV/AIDS, especially after the widespread...
Autores principales: | Bhalerao, Aditya, Cucullo, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120396/ https://www.ncbi.nlm.nih.gov/pubmed/36030572 http://dx.doi.org/10.1016/j.ejcb.2022.151271 |
Ejemplares similares
-
Assessing the protective effect of rosiglitazone against electronic cigarette/tobacco smoke-induced blood–brain barrier impairment
por: Sivandzade, Farzane, et al.
Publicado: (2019) -
A Quasi-Physiological Microfluidic Blood-Brain Barrier Model for Brain Permeability Studies
por: Noorani, Behnam, et al.
Publicado: (2021) -
Blood-Brain Barrier Abnormalities Caused by HIV-1 gp120: Mechanistic and Therapeutic Implications
por: Louboutin, Jean-Pierre, et al.
Publicado: (2012) -
A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity
por: Kadry, Hossam, et al.
Publicado: (2020) -
Traumatic Brain Injury and Blood–Brain Barrier (BBB): Underlying Pathophysiological Mechanisms and the Influence of Cigarette Smoking as a Premorbid Condition
por: Sivandzade, Farzane, et al.
Publicado: (2020)